Envista Holdings Corp

NVST

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Deerfield Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementNEWFeb 17, 2026

Shares: 2,280,498Value: $49.5M

# Signal Note: Deerfield Management Initiates $49.5M Position in Envista (NVST) Deerfield's new $49.5M stake in Envista suggests conviction in the dental equipment/CAD-CAM platform operator's standalone economics or potential M&A optionality. NVST trades at ~8-9x EV/EBITDA with 60%+ gross margins, making it a defensive healthcare play. Catalyst timing unclear without recent clinical/commercial developments, but worth monitoring for any strategic partnerships in digital dentistry or margin expansion catalysts.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

RDNT1 fund VTR1 fund PHVS1 fund PMVP1 fund ALHC1 fund ATRC1 fund BCRX1 fund NBIX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: